Depression is common among adolescents, affecting greater than 12% of youth in a given year. Studies have shown aberrant amygdala connectivity in depressed adolescents, compared with controls; however, no studies have examined whether these abnormalities precede and heighten risk for depressive symptom expression. This study used resting state functional connectivity (RSFC) magnetic resonance imaging to examine neurobiological markers of escalating depression symptoms in adolescents (ages 12-16 years; free from psychopathology at baseline). Of a large sample of adolescents, 18 showed ≥ 1 S.D. increase in depression scale t-scores over time ("escalators"; time to escalation ranging from 6 to 54 months in follow up) and were matched and compared to 19 youth showing stable CDI scores over time ("controls"). Whole-brain analyses on baseline RSFC data using an amygdala seed region-of-interest (ROI) showed that controls had greater RSFC, relative to escalators, between the right amygdala and left inferior frontal and supramarginal gyrus and right mid-cingulate cortex. Additionally, relative to escalators, control youth had less RSFC between the left amygdala and cerebellum. Findings suggest a possible neurobiological marker of increasing depressive symptoms during adolescence, characterized in part by reduced fronto-limbic connectivity, suggesting a premorbid deficiency in top-down emotional regulation.
Introduction
Adolescence is a developmental period characterized by social, physical, hormonal, and neural changes (Casey et al., 2008; Luciana, 2013) . These diverse changes, and their different developmental timelines, are thought to create a unique vulnerability to psychopathology that is specific to this time in life (Blakemore and Choudhury, 2006; Casey et al., 2008; Konrad et al., 2013; Ladouceur et al., 2012) . One such example is an increased incidence of depression. Major depressive disorder (MDD) is common among adolescents, affecting over 12% of youth in a given year (SAMSHA, 2015) . Furthermore, adolescent-onset MDD is associated with more severe and chronic depression across the lifespan, as well increased suicide rates (Zisook et al., 2007) , the latter of which is the second leading cause of mortality among those aged 10-24 years (Heron, 2016) . Given the dramatic increase in rates of MDD that occurs during the adolescent years (Hankin et al., 1998) , identifying potential neurobiological biomarkers and underpinnings of risk for MDD is crucial for ultimately informing prevention efforts.
The prefrontal cortex and limbic system both undergo major neurodevelopment and reorganization during adolescence, which affects the ways in which adolescents assess, process, and evaluate both risk and emotion (Heller and Casey, 2016; Steinberg, 2005) . The amygdala, a key brain structure within the limbic system, detects and responds to threats and aids in the formulation of emotional responses (Baxter and Murray, 2002; LeDoux, 2003; Ochsner et al., 2012) and responds differentially to emotional stimuli in adolescents when compared to adults (Casey, 2015) . The prefrontal cortex (PFC) is one of the last brain regions to develop and is broadly responsible for higher order cognitive functions, including planning and cognitive control (Blakemore and Choudhury, 2006; Fuster, 2001) . The PFC also plays a major role in emotional behavior when working in tandem with the limbic system (Fuster, 2001) . More specifically, the functionally connected circuits of the amygdala and PFC have been shown to be the principal neural correlates of emotional regulation and processing (Ochsner et al., 2002; Ochsner and Gross, 2005) , circuitry showing developmental change during adolescence (Gabard-Durnam et al., 2014) . Grounded in existing knowledge of emotional neural circuitry and
